Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
The report details the trend, potential and market size of Tildrakizumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tildrakizumabmarket, defines the market attractiveness level of Tildrakizumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tildrakizumab industry, describes the types of Tildrakizumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tildrakizumab market and the development prospects and opportunities of Tildrakizumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tildrakizumab market in Chapter 13.
By Player:
Sun Pharma
By Type:
Prefilled 100 mg/mL solution
Type II
By End-User:
Hospital
Drug store
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tildrakizumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tildrakizumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tildrakizumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tildrakizumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tildrakizumab Market Analysis and Outlook to 2022
-
7.1 Global Tildrakizumab Consumption (2017-2022)
-
7.2 United States Tildrakizumab Consumption (2017-2022)
-
7.3 Europe Tildrakizumab Consumption (2017-2022)
-
7.4 China Tildrakizumab Consumption (2017-2022)
-
7.5 Japan Tildrakizumab Consumption (2017-2022)
-
7.6 India Tildrakizumab Consumption (2017-2022)
-
7.7 South Korea Tildrakizumab Consumption (2017-2022)
8 Region and Country-wise Tildrakizumab Market Analysis and Outlook to 2028
-
8.1 Global Tildrakizumab Consumption Forecast (2022-2028)
-
8.2 United States Tildrakizumab Consumption Forecast (2022-2028)
-
8.3 Europe Tildrakizumab Consumption Forecast (2022-2028)
-
8.4 China Tildrakizumab Consumption Forecast (2022-2028)
-
8.5 Japan Tildrakizumab Consumption Forecast (2022-2028)
-
8.6 India Tildrakizumab Consumption Forecast (2022-2028)
-
8.7 South Korea Tildrakizumab Consumption Forecast (2022-2028)
9 Global Tildrakizumab Market Outlook by Types and Applications to 2022
-
9.1 Global Tildrakizumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prefilled 100 mg/mL solution Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type II Consumption and Growth Rate (2017-2022)
-
9.2 Global Tildrakizumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug store Consumption and Growth Rate (2017-2022)
10 Global Tildrakizumab Market Outlook by Types and Applications to 2028
-
10.1 Global Tildrakizumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prefilled 100 mg/mL solution Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type II Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tildrakizumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug store Consumption Forecast and Growth Rate (2022-2028)
11 Global Tildrakizumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tildrakizumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tildrakizumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tildrakizumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tildrakizumab Market Competitive Analysis
-
14.1 Sun Pharma
-
14.1.1 Sun Pharma Company Details
-
14.1.2 Sun Pharma Tildrakizumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sun Pharma Tildrakizumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tildrakizumab
-
Figure Tildrakizumab Picture
-
Table Global Tildrakizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tildrakizumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tildrakizumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tildrakizumab Consumption by Country (2017-2022)
-
Figure United States Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Table Europe Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Figure China Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Figure India Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tildrakizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Tildrakizumab Consumption Forecast by Country (2022-2028)
-
Figure United States Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tildrakizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prefilled 100 mg/mL solution Consumption and Growth Rate (2017-2022)
-
Figure Global Type II Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug store Consumption and Growth Rate (2017-2022)
-
Figure Global Prefilled 100 mg/mL solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug store Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tildrakizumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tildrakizumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Sun Pharma (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Tildrakizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Tildrakizumab Product and Service
-
